Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical impacts of mesothelin expression in gastrointestinal carcinomas.
Einama T, Kawamata F, Kamachi H, Nishihara H, Homma S, Matsuzawa F, Mizukami T, Konishi Y, Tahara M, Kamiyama T, Hino O, Taketomi A, Todo S. Einama T, et al. World J Gastrointest Pathophysiol. 2016 May 15;7(2):218-22. doi: 10.4291/wjgp.v7.i2.218. World J Gastrointest Pathophysiol. 2016. PMID: 27190694 Free PMC article. Review.
C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.
Kawamata F, Homma S, Kamachi H, Einama T, Kato Y, Tsuda M, Tanaka S, Maeda M, Kajino K, Hino O, Takahashi N, Kamiyama T, Nishihara H, Taketomi A, Todo S. Kawamata F, et al. Among authors: einama t. J Gastroenterol. 2014 Jan;49(1):81-92. doi: 10.1007/s00535-013-0773-6. Epub 2013 Mar 20. J Gastroenterol. 2014. PMID: 23512344 Free article.
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model.
Mizukami T, Kamachi H, Fujii Y, Matsuzawa F, Einama T, Kawamata F, Kobayashi N, Hatanaka Y, Taketomi A. Mizukami T, et al. Among authors: einama t. Oncotarget. 2018 Sep 18;9(73):33844-33852. doi: 10.18632/oncotarget.26117. eCollection 2018 Sep 18. Oncotarget. 2018. PMID: 30333914 Free PMC article.
Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
Matsuzawa F, Kamachi H, Mizukami T, Einama T, Kawamata F, Fujii Y, Fukai M, Kobayashi N, Hatanaka Y, Taketomi A. Matsuzawa F, et al. Among authors: einama t. BMC Cancer. 2021 Feb 26;21(1):200. doi: 10.1186/s12885-020-07722-3. BMC Cancer. 2021. PMID: 33637083 Free PMC article.
77 results